J

Johnson & Johnson

Makes prescription drugs and medical devices

Vice President Global Medical Affairs - Solid Tumors

Biology & BiotechConfirmed live in the last 24 hours
Full-timeRaritan, NJ, USA

About the Job

Requirements

  • An advanced degree (MPH, PharmD, PhD, or MD) is required.
  • A minimum of 15 years of experience in Medical Affairs and/or R&D, including strong global experience with multi-billion-dollar brands, is required.
  • Solid Tumor experience is required.
  • Experience leading, coaching, and motivating talent and teams at scale across a matrix is required.
  • Experience leading Medical Affairs teams, with strong business acumen and understanding of global oncology market dynamics and value drivers, is required.
  • Experience engaging and partnering with key opinion leaders and important external stakeholders is required.
  • Experience with new product launches and launch excellence processes is required.
  • Experience successfully leading global Medical Affairs teams is required.
  • Ability to communicate as a medical spokesperson to senior-level audiences and media is required.
  • Demonstrated ethical and compliant leadership aligned with Credo principles is required.

Responsibilities

  • Lead the Global Medical Affairs solid tumor team through growth and change; develop global medical adoption strategies and worldwide integrated evidence generation strategies, develop lifecycle management strategies, and partner with regional Medical Affairs and R&D to integrate Medical Affairs perspectives into clinical development.
  • Lead evidence generation and communication activities and ensure appropriate communication of data internally and externally through publications and Medical Science Liaison activities.
  • Execute complex clinical development programs to support key Oncology medicines and explore new disease areas in which these medicines may have clinical value.
  • Develop the in-house solid tumor global Medical Affairs organization to ensure high team effectiveness; build talent and competencies to support integrated data generation and communication; and lead digital transformation to engage external customers and stakeholders.
  • Build the Oncology organization’s external reputation as credible experts and indispensable partners.
  • Ensure operations and activities comply with Johnson & Johnson principles, Health Care Compliance, and other applicable guidelines.
  • Ensure consistency and harmonization of critical policies, processes, and procedures for the Medical Affairs organization.
  • Design strategic and tactical plans to grow the solid tumor oncology portfolio and support transformational patient outcomes.
  • Develop clinical, scientific, and value-oriented differentiation for investigational and marketed products through worldwide evidence generation and scientific communications.
  • Prepare for launches of new assets over the next two to three years in current and new therapeutic areas and business models.
  • Develop a portfolio approach in genitourinary, lung, and gastrointestinal malignancies.
  • Champion worldwide medical adoption strategies for solid tumors, supported by integrated worldwide evidence generation plans.
  • Build advocacy and partnerships with external stakeholders, medical societies, and patient organizations, working with Oncology and Hematology Medical Affairs leaders and global functional leaders.
  • Shape clinical development of lifecycle and new products using insights and needs captured from worldwide stakeholders.
  • Expand the Oncology pipeline through partnership with business development and R&D teams.

Desired Qualifications

  • Experience in global or international markets is desired.
  • Experience with global strategic planning and portfolio development is desired.
  • Willingness to travel domestically and internationally 25% of the time.

About the Company

Johnson & Johnson

Makes prescription drugs and medical devices

Johnson & Johnson develops prescription medicines and makes medical devices for hospitals, and unlike most big drugmakers, it runs both businesses under one roof. In 2015, its Darzalex became the first antibody drug approved for multiple myeloma, a blood cancer. Its medicines treat cancer, immune diseases such as psoriasis, and mental illnesses such as depression, and patented drugs bring in most of its sales. Its MedTech unit makes heart pumps, catheters that treat irregular heartbeats, surgical sutures, and Acuvue contact lenses. It was founded in 1886 to make sterile surgical dressings, is based in New Brunswick, New Jersey, and spun off its consumer brands, such as Tylenol and Band-Aid, as Kenvue in 2023.

Company size
10,001+
Company stage
IPO
Headquarters
New Brunswick, NJ
Founded
1886

Recently Posted Jobs

Explore more opportunities at Johnson & Johnson

See more jobs